OKTO Ophtho, headquartered in Costa Mesa, California
USA, is an innovation-driven, surgical technology company, focused
on the development and commercialization of specialty technologies
for eye care.
Founded in 2000, OKTO is passionately focused on unique, leading-edge
surgical technologies that: (1) significantly improve the quality
of life for patients; (2) elevate the performance and productivity
of eye care professionals; and (3) lower costs to the healthcare
OKTO currently holds leadership positions with surgical devices
for oculoplastic surgeries and bio-implant technologies for ocular
surface/ophthalmic reconstructive surgeries.
OKTO has a well-established network of alliances for the development,
manufacturing and distribution of innovative surgical technologies.
The Company uses a variety of innovation methods and strategic collaborations
to develop and deliver technologies offering solutions. Key assets:
- OKTO is led and directed by an uncompromising management team
made up of industry leaders in sales, marketing, product development,
operations and regulatory affairs.
- OKTO Surgical Sales includes over forty specialty-trained,
independent U.S. surgical sales reps.
- In 2002, OKTO formally formed its OKTO Surgical Advisory Board,
comprising of worldwide surgeon-leaders in ophthalmology.
- The Company has formed and currently maintains strategic alliances
with Innovative Ophthalmic Products, Inc. (IOP, Inc.), Advanced
Meditech International (AMI) and Anthrogenesis Corporation (Cedar
OKTO Ophtho is a privately held California corporation.
Click here for Mission and Values
To view OKTO Philosophy click here